- Home
- HCWB vs NXPL Comparison
HCWB vs NXPL Comparison
Compare HCWB & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCWB | NXPL |
|---|---|---|
| Founded | 2018 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8M | 16.3M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | HCWB | NXPL |
|---|---|---|
| Price | $3.26 | $6.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $35.00 | N/A |
| AVG Volume (30 Days) | ★ 61.4K | 25.2K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.29 |
| EPS | ★ 0.37 | N/A |
| Revenue | $4,099,750.00 | ★ $5,869,558.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $9.14 | ★ N/A |
| Revenue Growth | N/A | ★ 2.50 |
| 52 Week Low | $0.25 | $0.34 |
| 52 Week High | $7.35 | $8.37 |
Technical Indicators
Market Signals| Indicator | HCWB | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 52.15 | 54.72 |
| Support Level | $0.37 | $5.54 |
| Resistance Level | $4.00 | $7.13 |
| Average True Range (ATR) | 0.44 | 0.39 |
| MACD | -0.03 | 0.06 |
| Stochastic Oscillator | 50.53 | 53.54 |
Price Performance
Historical ComparisonAbout HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.